OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC327542 Human cDNA pCMV6-Neo GLRA1 (untagged)-Human glycine receptor alpha 1 (GLRA1) transcript variant 1 (10ug) NM_001146040.1 $680 Immediate
RC228907 Human ORF PS100001 GLRA1 (Myc-DDK-tagged)-Human glycine receptor, alpha 1 (GLRA1), transcript variant 1 $540 3-4 weeks
RC228907L1 Human ORF PS100064 Lenti-ORF clone of GLRA1 (Myc-DDK-tagged)-Human glycine receptor, alpha 1 (GLRA1), transcript variant 1, (10ug) $910 5-6 weeks
RC228907L2 Human ORF PS100071 Lenti-ORF clone of GLRA1 (mGFP-tagged)-Human glycine receptor, alpha 1 (GLRA1), transcript variant 1, (10ug) $1000 5-6 weeks
RG228907 Human ORF PS100010 GLRA1 (GFP-tagged) - Human glycine receptor, alpha 1 (GLRA1), transcript variant 1 $590 3-4 weeks
TF312749 Human shRNA pRFP-C-RS GLRA1 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $650 2 Weeks
TG312749 Human shRNA pGFP-V-RS GLRA1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 2 Weeks
TR312749 Human shRNA pRS GLRA1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 2 Weeks
/ UTR pMirTarget 3`UTR clone of glycine receptor alpha 1 (GLRA1) transcript variant 1 for miRNA target validation NM_001146040.1 $495 3-4 weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title